Diapositiva 28 de 30
Notas:
El caso estudio de las heparinas incluye una detallada descripción de las dosis utilizadas, lo que permitiria la reproducción del estudio:
“Patients in the unfractionated heparin cohort received continuous intravenous infusion of unfractionated heparin by automatic pump at an average dosage of 30 000 U/d. Treatment was administered for a total of 6 days in a monitored inpatient setting.
Patients in the low-molecular-weight heparin cohort received fixed-dose enoxaparin, 1 mg/kg of body weight subcutaneously, twice daily for 6 days.”
